Lerapolturev
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Lerapolturev, covering 2024-10-24 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: LUMINOS-102: Lerapolturev With or Without Immune Checkpoint Blockade in Advanced PD-1 Refractory Melanoma [Phase 2]